MedTrace Logo

Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale

NCT00251342 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 460

Last updated 2007-04-05

No results posted yet for this study

Summary

The objective of the present study is to evaluate the effectiveness of postnatal depression screening by comparing the mental health outcome (at 6 months postpartum) of mothers under the Edinburgh Postnatal Depression Scale (EPDS) screening programme versus usual clinical practice (usual practice), using randomized controlled trial design. With the use of the EPDS for the screening of postnatal depression, it is expected that more mothers in need of intervention (including mental health intervention, guidance in childcare and parenting, counseling in family relationships, etc) will be picked up and offered appropriate intervention, compared to the usual practice. It is hypothesized that the mental health of the group of women under the EPDS screening programme will be better than those under the usual practice, on subsequent follow-up.

Conditions

  • Depression, Postpartum

Interventions

PROCEDURE

Edinburgh Postnatal Depression Scale

Sponsors & Collaborators

  • Hong Kong Department of Health

    collaborator UNKNOWN

  • The University of Hong Kong

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Dominic TS Lee, M.D. · Department of Psychiatry, The Chinese University of Hong Kong

  • Shirley SL Leung, MPH · Family Health Service, Department of Health, HKSAR

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-10-31
Completion
2008-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00251342 on ClinicalTrials.gov